HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Abierto

SectorFinanzas

210.4 3.34

Resumen

Variación precio

24h

Actual

Mínimo

204

Máximo

210.8

Métricas clave

By Trading Economics

Ingresos

-34M

71M

Ventas

85M

1.3B

P/B

Media del Sector

29.8

22.989

BPA

0.08

Rentabilidad por dividendo

3.47

Margen de beneficios

5.575

Empleados

10,910

EBITDA

57M

338M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+44.01% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.47%

4.69%

Próximas Ganancias

4 ago 2026

Próxima Fecha de Ex Dividendo

20 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-793M

4.1B

Apertura anterior

207.06

Cierre anterior

210.4

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

157 / 439 Clasificación en Finance

ConvaTec Group PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Acerca de ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat